Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,625 | 3 | 71.6% |
| Food and Beverage | $1,044 | 18 | 28.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,997 | 17 | $0 (2024) |
| Cadwell Industries, INC | $1,000 | 1 | $0 (2017) |
| C. R. Bard, Inc. & Subsidiaries | $525.00 | 1 | $0 (2017) |
| Eisai Inc. | $90.13 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $56.47 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $196.27 | 3 | UCB, Inc. ($196.27) |
| 2023 | $67.18 | 3 | UCB, Inc. ($67.18) |
| 2022 | $82.27 | 1 | UCB, Inc. ($82.27) |
| 2021 | $1,190 | 2 | UCB, Inc. ($1,190) |
| 2020 | $123.70 | 5 | UCB, Inc. ($123.70) |
| 2019 | $125.00 | 1 | UCB, Inc. ($125.00) |
| 2017 | $1,884 | 6 | Cadwell Industries, INC ($1,000) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $159.25 | General |
| 08/22/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Neurology | ||||||
| 04/25/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Neurology | ||||||
| 12/21/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Neurology | ||||||
| 06/22/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Neurology | ||||||
| 01/28/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Neurology | ||||||
| 02/28/2022 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $82.27 | General |
| 12/15/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $89.97 | General |
| Category: Neurology | ||||||
| 06/09/2021 | UCB, Inc. | Briviact (Drug) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Neurology | ||||||
| 11/19/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Neurology | ||||||
| 11/18/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Neurology | ||||||
| 11/18/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: Neurology | ||||||
| 07/09/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Neurology | ||||||
| 03/09/2020 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $70.76 | General |
| 08/07/2019 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 11/02/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $56.47 | General |
| Category: NEPHROLOGY | ||||||
| 10/05/2017 | C. R. Bard, Inc. & Subsidiaries | — | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| 09/18/2017 | UCB, Inc. | Vimpat (Drug) | Food and Beverage | In-kind items and services | $97.88 | General |
| Category: Neurology | ||||||
| 07/18/2017 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $90.13 | General |
| Category: Neurology | ||||||
| 03/09/2017 | Cadwell Industries, INC | Cadwell Arc Essentia (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Neurodiagnostic | ||||||
| 03/07/2017 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $114.70 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 102 | 184 | $168,500 | $27,625 |
| 2022 | 2 | 40 | 82 | $85,435 | $13,886 |
| 2021 | 5 | 96 | 146 | $136,585 | $22,763 |
| 2020 | 2 | 90 | 195 | $196,100 | $34,373 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 50 | 125 | $143,780 | $22,446 | 15.6% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 20 | 23 | $11,040 | $2,078 | 18.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 18 | $6,390 | $1,811 | 28.3% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Facility | 2023 | 17 | 18 | $7,290 | $1,290 | 17.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 27 | 67 | $74,035 | $12,184 | 16.5% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 13 | 15 | $11,400 | $1,702 | 14.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 36 | 71 | $78,455 | $13,159 | 16.8% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 22 | 32 | $37,760 | $5,680 | 15.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 19 | $6,745 | $1,671 | 24.8% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 11 | 11 | $8,360 | $1,270 | 15.2% |
| 95813 | Measurement of brain wave activity (eeg) extended monitoring, 61-119 minutes | Facility | 2021 | 13 | 13 | $5,265 | $981.63 | 18.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 72 | 164 | $181,220 | $31,370 | 17.3% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 18 | 31 | $14,880 | $3,003 | 20.2% |
About Emily Gilmore
Emily Gilmore is a Neurology healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1508015223.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Emily Gilmore has received a total of $3,669 in payments from pharmaceutical and medical device companies, with $196.27 received in 2024. These payments were reported across 21 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($2,625).
As a Medicare-enrolled provider, Gilmore has provided services to 328 Medicare beneficiaries, totaling 607 services with total Medicare billing of $98,646. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location New Haven, CT
- Active Since 09/17/2008
- Last Updated 12/13/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1508015223
Products in Payments
- Briviact (Drug) $1,587
- Cadwell Arc Essentia (Device) $1,000
- Vimpat (Drug) $97.88
- Fycompa (Drug) $90.13
- SAMSCA (Drug) $56.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in New Haven
Sharon Stoll, D.o, D.O
Neurology — Payments: $782,631
Dr. David Russell, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $390,295
Dr. Kenneth Marek, Md, MD
Neurology — Payments: $293,594
David Hafler, Md, MD
Neurology — Payments: $133,003
Stephen Waxman, Md, MD
Neurology — Payments: $125,575
Imran Quraishi, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $107,014